You are here:  > Authors > Editorial Policy

Editorial Policy

Manuscripts submitted to Antiviral Chemistry & Chemotherapy are considered for publication on the understanding that the work contained therein has not been submitted simultaneously to another journal. Copies of related manuscripts submitted elsewhere or in press should accompany the submitted manuscript.

All submissions must be accompanied by a covering letter, signed by all authors (or by the corresponding author on behalf of all others) stating that all authors have contributed to the paper and are familiar with the contents of the final draft, and that all authors meet the criteria for authorship as established by the International Committee of Medical Journal Editors. The letter should also state whether an author has any conflict of interest.

Sources of funding, any influence the funding source might have had on the analysis and reporting of the results and any related interest must be declared in the Acknowledgements section of your manuscript. Illustrations and other material obtained from other sources must be acknowledged and permission for reproduction must be obtained from the publisher.


All manuscripts should be submitted via our online Manuscript Central™ portal. Manuscripts should not be submitted via email or post.
Papers will be peer-reviewed before acceptance. Priority and time of publication of accepted material will be decided by the Editors. The Editors retain the right to shorten material accepted for publication. This can include subediting the text for style. The Editors endorse the guidelines on good publication practice from the Committee on Publication Ethics (COPE).

Immediate publication

Articles from Volume 21 Issue 4 and onward will be eligible for immediate publication. Once accepted, manuscripts will be published online as soon as one working day from a decision, before any editorial amends. Immediate publication is subject to provision of a copyright transfer and confirmation that the manuscript includes all required components outlined in the Author Guidelines.


Authors must conform to current standards with regards to the use of animals for experimental study and the normal requirements for obtaining consent from the relevant ethical committees for the conduct of clinical trials.


Antiviral Chemistry & Chemotherapy has an open archive initiative wherein research articles are freely accessible after 12 months of their publication date. We also extend open access to all articles, regardless of age, to developing nations via HINARI, which provides free online access to institutions within countries whose resources would otherwise prevent them from subscribing and accessing journal content.

Copyright © Nucleus Global 2017. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.